Virtus Biotech ETF (BBP)

Assets	$101.39M
Expense Ratio	0.34%
PE Ratio	n/a
Shares Out	1.05M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	12,892
Open	96.43
Previous Close	96.49
Day's Range	93.36 - 97.58
52-Week Low	60.91
52-Week High	105.21
Beta	0.56
Holdings	70
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

19.37% of assets

Name	Symbol	Weight
Crinetics Pharmaceuticals, Inc.	CRNX	3.25%
Kiniksa Pharmaceuticals International, plc	KNSA	2.02%
Verastem, Inc.	VSTM	1.99%
Omeros Corporation	OMER	1.83%
Nuvation Bio Inc.	NUVB	1.82%
Precigen, Inc.	PGEN	1.79%
Protagonist Therapeutics, Inc.	PTGX	1.69%
ACADIA Pharmaceuticals Inc.	ACAD	1.68%
Xeris Biopharma Holdings, Inc.	XERS	1.66%
BridgeBio Pharma, Inc.	BBIO	1.65%

Performance

BBP had a total return of 52.09% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.68%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Aug 1, 2026

Data Sources Report a data error